Research Article

Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway

Figure 1

Liensinine inhibited the viability and proliferation of osteosarcoma cells. (a) The chemical structure of liensinine. (b) The viability of human normal osteoblasts (hFOB 1.19) after being treated with liensinine for 24 h was detected by CCK-8 assay. (c–f) The viability of human osteosarcoma cells (SaOS-2, MG-63, 143B, and U2OS) after being treated with liensinine for 24 h was detected by CCK-8 assay. (g) Changes in cell morphology of SaOS-2 and 143B cells were observed after liensinine treatment for 24 h; μm. (h) The proliferation of SaOS-2 and 143B cells after being treated with liensinine was detected by colony formation assay. in each group. The columns and errors bars represent means and SD. , , and vs. 0 μM.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)